Pretoria pharmacy ordered to recall unregistered weight-loss medicines after regulatory raid.
The South African Health Products Regulatory Authority (SAHPRA), working alongside the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered weight-loss medicines containing semaglutide and tirzepatide, following a raid at a Pretoria pharmacy that uncovered serious regulatory breaches.
A joint investigation conducted at iDexis (Pty) Ltd, trading as Sentra Pharmacy in Silverton, Pretoria, on May 11, resulted in the seizure of all injectable GLP-1 and GIP products found on site after authorities uncovered what they described as critical non-compliance with South African medicines laws.
The inspection focused on medicines containing semaglutide, tirzepatide, and combination formulations marketed for weight loss.
"The investigation revealed that the company was producing and supplying medicines under the pretext of 'compounding', but outside the legal framework permitted under South African law," said SAHPRA.
